Ostatní
Návod 
UroGen Pharma Ltd.
URGN
Souhrn
Výkazy
Ukazatele
Profil
Držitelé
Návštěvnost webu
Konkurence
Zprávy společnosti
Kapitalizace
1.1B
Obrat
0B
Zisk
0B
Aktiva
0B
Dluh
0B
ROE
99%
ROA
-62%
PE
-6
PS
8
Cena 1R
3-30
⌀ Cena
16.77
Dividenda
0.0(0.0%)
Čtvrtletní 10-Q
Celoroční 10-K
Nadcházející oznámení zisků
09-03-2026
Poslední dividenda
Profil
Společnost UroGen Pharma s.r.o., biotechnologická společnost, se zabývá vývojem a uváděním na trh nových řešení pro speciální rakovinu a uroteliální onemocnění. Nabízí RTGel, polymerní biokompatibilní a reverzní termální želatinu hydrogel pro zlepšení terapeutických profilů stávajících léků; a Jelmyto pro pyelokalyceální roztok. Hlavní kandidátkou na přípravek je UGN-102, který je součástí klinických studií fáze III pro léčbu několika forem nesvalového invazivního uroteliálního karcinomu, které zahrnují uroteliální karcinom horních cest nižšího stupně a nesvalový invazivní karcinom močového měchýře nižšího stupně. Vyvíjí se také UGN- 301 pro léčbu vysoce závažného nesvalového invazivního karcinomu močového měchýře. Společnost má licenční smlouvu se společností Allergan Pharmaceuticals International Limited na vývoj a prodej farmaceutických výrobků, které obsahují RTGel a klostridiální toxiny; Agenus Inc. na vývoj, výrobu, používání, prodej, dovoz a uvádění na trh produktů společnosti Agenus pro léčbu rakoviny močového traktu prostřednictvím intravesického porodu; a strategickou výzkumnou spolupráci s MD Anderson na pokročilé výzkumné léčbě vysoce kvalitního karcinomu močového měchýře. UroGen Pharma Ltd. byla založena v roce 2004 a sídlí v Princetonu v New Jersey.
Sektor
Healthcare
Odvětví
Biotechnology
Počet zaměstnanců
234
Založení
2017-05-04
Podobné společnosti
$ 18.44
+ $ 0.81
$ 11.85
+ $ 0.15
$ 14.19
+ $ 0.29
$ 7.87
- $ 0.01
$ 12.41
+ $ 0.10
$ 19.42
+ $ 0.18
$ 33.26
- $ 6.39
Zahraniční články
Výsledovka
Rozvaha
Peněžní toky
Výsledovka
Výsledovka
Rozvaha
Peněžní toky
V miliónech (USD)
| Revenue | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 109.8 | 109.8 | 90.4 | 82.7 | 64.4 | 48.0 | 11.8 | 0.0 | 1.1 | 8.2 | 17.5 | 0.0 | |
| Cost of Revenues | 12.4 | 12.4 | 8.9 | 9.4 | 7.7 | 5.2 | 1.0 | 0.0 | 1.8 | 0.6 | 0.0 | 0.0 | |
| Gross Profit | 97.3 | 97.3 | 81.5 | 73.4 | 56.7 | 42.9 | 10.8 | 0.0 | -0.7 | 7.6 | 17.5 | 0.0 |
| Revenue | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 37.8 | 27.5 | 24.2 | 20.3 | 24.6 | 25.2 | 21.8 | 18.8 | 23.5 | 20.9 | |
| Cost of Revenues | 3.3 | 3.3 | 3.6 | 2.3 | 2.5 | 2.5 | 2.2 | 1.7 | 2.3 | 2.4 | |
| Gross Profit | 34.5 | 24.2 | 20.7 | 17.9 | 22.1 | 22.8 | 19.6 | 17.1 | 21.2 | 18.5 |
| Operating Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.0 | 0.0 | 0.0 | 45.6 | 52.9 | 47.6 | 47.3 | 49.3 | 36.9 | 18.7 | 10.3 | 10.5 | |
| Selling General & Admin Expenses | 0.0 | 0.0 | 0.0 | 93.3 | 82.8 | 87.5 | 90.2 | 60.2 | 39.6 | 8.8 | 6.4 | 1.9 | |
| Depreciation & Amortization | 2.4 | 2.4 | 0.3 | 1.7 | 1.0 | 17.3 | 2.0 | 1.3 | 0.4 | 0.2 | 0.2 | 0.1 | |
| Total Operating Expenses | 222.2 | 222.2 | 178.3 | 138.9 | 135.7 | 135.2 | 137.5 | 109.5 | 76.5 | 27.5 | 16.7 | 12.4 | |
| Operating Income | -124.9 | -124.9 | -96.8 | -65.5 | -79.0 | -92.3 | -126.7 | -109.5 | -77.2 | -20.0 | 0.8 | -12.4 |
| Operating Income | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 11.3 | 10.2 | ||
| Selling General & Admin Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 24.6 | 21.8 | ||
| Depreciation & Amortization | 0.7 | 0.6 | 0.6 | 0.5 | 0.1 | 0.3 | 0.3 | 0.4 | 0.4 | 0.4 | ||
| Total Operating Expenses | 53.7 | 51.6 | 62.1 | 54.8 | 49.8 | 40.3 | 45.5 | 42.8 | 35.9 | 32.0 | ||
| Operating Income | -19.1 | -27.4 | -41.4 | -36.9 | -27.7 | -17.5 | -25.8 | -25.7 | -14.6 | -13.5 |
| Net Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 6.0 | 6.0 | 8.9 | 2.6 | 1.0 | 0.2 | 1.6 | 4.6 | 1.9 | 0.0 | 0.0 | 0.0 | |
| Interest Expense | 33.8 | 33.8 | 12.5 | 14.7 | 8.4 | 0.0 | 0.0 | -4.3 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Expense | -28.6 | -28.6 | -27.3 | -32.8 | -29.0 | -17.1 | 1.6 | 4.3 | -0.1 | 0.0 | -2.7 | -0.3 | |
| IBT | -153.4 | -153.4 | -124.0 | -98.3 | -108.0 | -109.4 | -125.1 | -105.1 | -75.5 | -20.0 | -1.9 | -12.7 | |
| Income Tax Expense | 0.1 | 0.1 | 2.8 | 3.9 | 1.1 | 1.4 | 3.4 | -4.6 | 0.1 | 0.0 | 0.0 | 0.0 | |
| Net Income | -153.5 | -153.5 | -126.9 | -102.2 | -109.2 | -110.8 | -128.5 | -100.5 | -75.7 | -20.0 | -1.9 | -12.7 |
| Net Income | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 0.9 | 1.2 | 1.7 | 2.2 | 2.8 | 2.8 | 1.7 | 1.8 | 0.7 | 0.8 | ||
| Interest Expense | 13.0 | 8.0 | 8.8 | 4.1 | 3.9 | 2.7 | 3.5 | 2.4 | 9.1 | 3.8 | ||
| Other Expense | -7.5 | -7.0 | -7.5 | -6.5 | -7.2 | -6.0 | -7.5 | -6.5 | -7.6 | -8.4 | ||
| IBT | -26.6 | -34.4 | -48.9 | -43.5 | -34.9 | -23.6 | -33.4 | -32.2 | -22.2 | -21.9 | ||
| Income Tax Expense | -0.3 | -1.1 | 1.0 | 0.4 | 2.6 | 0.1 | 0.0 | 0.1 | 3.9 | 0.0 | ||
| Net Income | -26.4 | -33.3 | -49.9 | -43.8 | -37.5 | -23.7 | -33.4 | -32.3 | -26.0 | -21.9 |
| Per Share Data | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $-3.55 | $-4.79 | $-4.96 | $-5.90 | $-4.90 | $-4.80 | $-2.06 | $-0.16 | $-1.06 | |
| EPS Diluted | $0.00 | $0.00 | $0.00 | $-3.55 | $-4.79 | $-4.96 | $-5.90 | $-4.90 | $-4.80 | $-2.06 | $-0.16 | $-1.06 | |
| Shares Outstanding | 49.2 | 48.1 | 42.9 | 28.8 | 22.8 | 22.3 | 21.8 | 20.5 | 15.8 | 9.7 | 12.0 | 12.0 | |
| Diluted Shares Outstanding | 49.2 | 48.1 | 42.9 | 28.8 | 22.8 | 22.3 | 21.8 | 20.5 | 15.8 | 9.7 | 12.0 | 12.0 |
| Per Share Data | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $-0.72 | $-0.68 | ||
| EPS Diluted | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $-0.72 | $-0.68 | ||
| Shares Outstanding | 49.2 | 48.1 | 47.7 | 47.4 | 47.0 | 43.1 | 36.8 | 33.4 | 36.2 | 32.3 | ||
| Diluted Shares Outstanding | 49.2 | 48.1 | 47.7 | 47.4 | 47.0 | 43.1 | 36.8 | 33.4 | 36.2 | 32.3 |
| Current Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 220.8 | 172.0 | 95.0 | 55.4 | 44.4 | 103.9 | 49.7 | 101.3 | 37.0 | 21.4 | 18.0 | |
| Short Term Investments | 21.1 | 64.7 | 42.0 | 44.6 | 44.8 | 49.2 | 97.4 | 0.0 | 36.0 | 0.0 | 0.0 | |
| Total Cash & ST Investments | 241.9 | 236.7 | 137.0 | 100.0 | 89.8 | 103.9 | 147.1 | 101.3 | 73.0 | 21.4 | 18.0 | |
| Accounts Receivable | 17.4 | 20.3 | 15.4 | 12.7 | 11.7 | 7.0 | 0.0 | 0.0 | 0.2 | 0.1 | 0.0 | |
| Inventory | 7.4 | 9.2 | 5.7 | 4.3 | 4.8 | 2.0 | 0.0 | 0.0 | 0.3 | 0.1 | 0.0 | |
| Other Current Assets | 12.2 | 9.9 | 11.1 | 11.1 | 7.5 | 3.4 | 1.0 | 0.7 | 1.0 | 0.4 | 1.1 | |
| Total Current Assets | 279.0 | 276.1 | 169.2 | 128.9 | 114.4 | 115.6 | 148.6 | 102.2 | 74.5 | 22.0 | 19.1 |
| Current Assets | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 90.0 | 92.9 | 104.0 | 172.0 | 124.9 | 220.0 | 132.3 | 95.8 | 119.3 | 20.1 | |
| Short Term Investments | 37.0 | 64.1 | 91.9 | 64.7 | 124.7 | 21.1 | 32.6 | 42.0 | 28.1 | 27.2 | |
| Total Cash & ST Investments | 127.0 | 157.0 | 195.9 | 236.7 | 249.6 | 241.1 | 164.9 | 137.8 | 147.4 | 47.3 | |
| Accounts Receivable | 19.7 | 19.6 | 19.6 | 20.3 | 22.8 | 17.4 | 14.2 | 15.4 | 12.8 | 15.5 | |
| Inventory | 8.3 | 7.1 | 7.6 | 9.2 | 7.6 | 7.4 | 7.2 | 5.7 | 5.0 | 5.0 | |
| Other Current Assets | 13.5 | 13.1 | 14.1 | 9.9 | 15.1 | 13.0 | 10.5 | 11.1 | 16.9 | 13.5 | |
| Total Current Assets | 168.5 | 196.9 | 237.2 | 276.1 | 295.1 | 279.0 | 196.8 | 169.2 | 182.1 | 81.3 |
| Long-Term Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 1.8 | 3.8 | 2.4 | 3.7 | 3.1 | 4.2 | 4.7 | 0.9 | 0.8 | 0.7 | 0.3 | |
| Goodwill | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Intangible Assets | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Long-Term Investments | 0.4 | 5.0 | 4.5 | 0.0 | 0.7 | 1.9 | 48.6 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Long-Term Assets | 0.7 | 0.8 | 2.3 | 3.0 | 1.5 | 0.3 | 0.5 | 0.4 | 0.3 | 0.3 | 0.0 | |
| Total Long-Term Assets | 2.9 | 9.6 | 9.1 | 6.7 | 5.4 | 6.4 | 53.8 | 1.3 | 1.1 | 1.0 | 0.3 | |
| Total Assets | 281.8 | 285.7 | 178.3 | 136.2 | 119.7 | 122.0 | 202.4 | 103.6 | 75.6 | 23.1 | 19.4 |
| Long-Term Assets | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 9.2 | 6.2 | 5.4 | 3.8 | 1.7 | 1.8 | 2.0 | 2.4 | 2.7 | 3.0 | |
| Goodwill | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Intangible Assets | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Long-Term Investments | 0.4 | 4.6 | 4.5 | 5.0 | 4.6 | 0.2 | 0.7 | 4.7 | 6.5 | 8.0 | |
| Other Long-Term Assets | 6.9 | 1.0 | 0.5 | 0.8 | 0.5 | 0.8 | 1.1 | 2.0 | 2.3 | 3.0 | |
| Total Long-Term Assets | 16.5 | 11.8 | 10.4 | 9.6 | 6.8 | 2.9 | 3.8 | 9.1 | 11.5 | 14.0 | |
| Total Assets | 185.0 | 208.7 | 247.6 | 285.7 | 301.9 | 281.8 | 200.6 | 178.3 | 193.6 | 95.4 |
| Current Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 8.3 | 10.9 | 6.5 | 5.5 | 5.8 | 3.3 | 4.7 | 8.5 | 4.4 | 1.9 | 1.7 | |
| Short-Term Debt | 0.8 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Current Liabilities | 18.7 | 35.0 | 24.7 | 18.4 | 16.6 | 18.2 | 14.8 | 4.9 | 2.0 | 1.3 | 0.5 | |
| Current Liabilities | 34.2 | 45.9 | 31.2 | 23.9 | 22.4 | 21.4 | 19.5 | 13.5 | 7.0 | 3.1 | 2.2 |
| Current Liabilities | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 10.3 | 13.6 | 14.6 | 10.9 | 5.6 | 8.3 | 6.3 | 6.5 | 4.0 | 4.7 | |
| Short-Term Debt | 1.6 | 1.5 | 0.0 | 0.0 | 0.0 | 0.0 | 0.8 | 0.8 | 0.0 | 0.9 | |
| Other Current Liabilities | 30.4 | 32.4 | 27.4 | 35.0 | 27.2 | 25.9 | 14.1 | 23.9 | 21.7 | 21.2 | |
| Current Liabilities | 42.2 | 47.5 | 42.0 | 45.9 | 32.8 | 34.2 | 26.3 | 31.2 | 25.8 | 26.8 |
| Long-Term Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 97.8 | 123.4 | 99.4 | 99.1 | 0.4 | 1.5 | 2.6 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Capital Leases | 0.4 | 1.7 | 0.8 | 1.6 | 0.4 | 1.5 | 2.6 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Def. Tax Liability | 0.0 | 0.0 | 0.0 | 3.0 | 2.8 | 2.7 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Total Liabilities | 251.5 | 294.5 | 243.5 | 225.0 | 111.3 | 25.7 | 22.1 | 13.5 | 7.0 | 6.7 | 3.1 |
| Long-Term Liabilities | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 128.4 | 125.9 | 124.9 | 123.4 | 121.9 | 98.2 | 98.2 | 99.4 | 99.5 | 99.5 | |
| Capital Leases | 7.8 | 5.0 | 2.8 | 1.7 | 0.2 | 0.4 | 0.6 | 0.8 | 1.0 | 1.2 | |
| Def. Tax Liability | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 3.0 | 3.0 | |
| Total Liabilities | 300.5 | 302.1 | 294.1 | 294.5 | 276.4 | 251.5 | 240.7 | 243.5 | 235.6 | 233.8 |
| Total Common Equity | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Retained Earnings | -745.0 | -806.2 | -679.3 | -577.1 | -467.3 | -356.5 | -228.0 | -122.9 | -47.2 | -27.2 | -25.3 | |
| Comprehensive Income | 0.0 | 0.1 | 0.0 | -0.1 | 0.0 | 0.3 | 0.3 | -0.7 | -0.6 | -0.4 | -0.2 | |
| Total Common Equity | 30.3 | -8.8 | -65.2 | -88.7 | 8.4 | 96.4 | 180.3 | 90.1 | 68.5 | 16.3 | 16.3 |
| Total Common Equity | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | |
| Retained Earnings | -933.4 | -900.0 | -850.1 | -806.2 | -768.7 | -745.0 | -711.6 | -679.3 | -653.3 | -631.5 | |
| Comprehensive Income | 0.0 | 0.0 | 0.0 | 0.1 | 0.2 | 0.0 | 0.0 | 0.0 | -0.1 | -0.2 | |
| Total Common Equity | -115.4 | -93.4 | -46.5 | -8.8 | 25.5 | 30.3 | -40.1 | -65.2 | -42.0 | -138.4 |
| Other | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 99.0 | 123.4 | 100.2 | 99.1 | 0.4 | 1.5 | 2.6 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Book Value | 30.3 | -8.8 | -65.2 | -88.7 | 8.4 | 96.4 | 180.3 | 90.1 | 68.5 | 16.3 | 16.3 |
| Other | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Book Value | -115.4 | -93.4 | -46.5 | -8.8 | 25.5 | 30.3 | -40.1 | -65.2 | -42.0 | -138.4 |
| Cash Flow From Operating Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -104.3 | -153.5 | -126.9 | -102.2 | -109.8 | -110.8 | -128.5 | -105.1 | -75.7 | -20.0 | -1.9 | -12.7 | |
| Depreciation & Amortization | 1.6 | 2.4 | 1.2 | 1.7 | 1.8 | 1.8 | 2.0 | 1.3 | 0.4 | 0.2 | 0.2 | 0.1 | |
| Stock-Based Compensation | 9.8 | 12.0 | 13.1 | 9.3 | 10.6 | 23.1 | 28.0 | 30.0 | 30.6 | 6.3 | 2.0 | 0.4 | |
| Change Working Capital | -0.4 | -27.9 | 4.9 | 3.3 | -6.3 | -13.1 | -6.4 | 4.3 | 7.2 | 3.8 | 1.2 | 0.6 | |
| Change In Accounts Receivable | -1.6 | -12.8 | -4.9 | -2.7 | -1.0 | -4.7 | -7.0 | 0.0 | 3.3 | 0.1 | -0.1 | 0.0 | |
| Change In Accounts Payable | 0.9 | 0.3 | 10.9 | 4.2 | 0.3 | 2.0 | -1.2 | 2.9 | 4.2 | 2.5 | 0.5 | 1.2 | |
| Change In Inventories | -1.8 | -7.2 | -3.6 | -1.3 | -0.4 | -2.9 | -2.0 | 0.0 | 0.3 | -0.2 | -0.1 | 0.0 | |
| Other Non-cash Items | 11.7 | 4.6 | 10.9 | 11.5 | 16.1 | -1.2 | -1.5 | -0.9 | 0.1 | 0.2 | 2.7 | 4.1 | |
| Cash from Operations | -82.4 | 0.0 | 0.0 | -76.4 | -87.6 | -84.9 | -105.9 | -71.0 | -37.3 | -9.6 | 4.2 | -7.2 |
| Cash Flow From Operating Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -26.4 | -33.3 | -49.9 | -43.8 | -37.5 | -23.7 | -33.4 | -32.3 | -26.0 | -21.9 | |
| Depreciation & Amortization | 0.7 | 0.6 | 0.6 | 0.5 | 0.3 | 0.3 | 0.3 | 0.4 | 0.4 | 0.4 | |
| Stock-Based Compensation | 3.1 | 3.0 | 2.7 | 3.1 | 3.3 | 3.5 | 3.6 | 2.8 | 2.6 | 2.2 | |
| Change Working Capital | -18.3 | -10.1 | 5.2 | -2.6 | 15.5 | -9.1 | 2.6 | -4.0 | 6.6 | -1.1 | |
| Change In Accounts Receivable | -14.2 | -0.1 | 0.0 | 0.7 | 2.5 | -5.4 | -3.3 | 1.3 | -2.5 | 2.7 | |
| Change In Accounts Payable | 1.6 | 0.0 | 0.0 | 2.9 | 7.7 | -4.1 | 5.6 | 1.6 | 2.4 | -2.3 | |
| Change In Inventories | -8.6 | -1.2 | 0.5 | 1.6 | -1.6 | -0.2 | -0.2 | -1.6 | -0.6 | 0.0 | |
| Other Non-cash Items | 2.5 | -2.5 | 1.6 | 0.8 | 4.8 | 1.4 | 3.3 | 1.5 | 7.6 | 0.2 | |
| Cash from Operations | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -13.1 | -17.3 |
| Cash Flow From Investing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | -0.2 | -0.3 | -0.3 | -0.2 | -0.3 | -0.8 | -1.2 | -0.3 | -0.6 | -0.3 | -0.7 | -0.3 | |
| Acquisitions | 6.7 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Investments | -24.6 | -77.4 | -128.0 | -49.8 | -63.0 | -51.9 | -29.7 | -197.7 | 0.0 | -36.0 | 0.0 | 0.0 | |
| Sales of Investment | 31.8 | 139.2 | 107.7 | 49.1 | 64.3 | 56.7 | 124.1 | 52.6 | 35.9 | 0.0 | 0.0 | 0.0 | |
| Other Investing Activities | 6.5 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -0.2 | -0.1 | -0.1 | -0.1 | 0.0 | |
| Cash from Investing | 6.7 | 0.0 | 0.0 | -1.0 | 1.1 | 4.1 | 93.2 | -145.6 | 35.3 | -36.4 | -0.8 | -0.3 |
| Cash Flow From Investing Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | 0.0 | -0.1 | -0.1 | 0.0 | -0.1 | -0.1 | -0.1 | 0.0 | -0.1 | -0.1 | |
| Acquisitions | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 11.3 | -0.5 | |
| Investments | -11.0 | 0.0 | 0.0 | -66.4 | -9.2 | -118.8 | 0.0 | 0.0 | -14.2 | -10.8 | |
| Sales of Investment | 98.8 | 0.0 | 0.0 | 40.4 | 70.0 | 12.1 | 12.1 | 13.5 | 3.2 | 11.3 | |
| Other Investing Activities | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -11.3 | 0.5 | |
| Cash from Investing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -11.0 | 0.4 |
| Cash Flow From Financing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | -0.7 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Debt Issued | 0.4 | 123.4 | 23.2 | 1.1 | 98.7 | -1.1 | -1.1 | 2.6 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Issuance of Common Stock | 166.8 | 0.0 | 0.0 | 67.4 | 0.0 | 0.0 | 15.9 | 161.7 | 64.2 | 60.8 | 0.0 | 0.0 | |
| Repurchase of Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Dividends Paid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Financing Activities | 170.9 | 0.0 | 0.0 | 49.6 | 97.1 | 72.3 | 0.7 | 3.6 | 2.2 | 0.7 | 0.0 | 21.6 | |
| Cash from Financing | 170.9 | 0.0 | 0.0 | 116.9 | 97.1 | 72.3 | 16.5 | 165.3 | 66.4 | 61.6 | 0.0 | 21.6 |
| Cash Flow From Financing Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Debt Issued | 129.9 | 2.5 | 2.5 | 1.6 | 1.5 | 23.7 | -0.8 | -1.2 | 0.7 | 0.0 | |
| Issuance of Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -0.4 | 67.4 | |
| Repurchase of Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Dividends Paid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Financing Activities | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 48.7 | |
| Cash from Financing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 116.1 |
| Cash position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | 94.9 | -61.0 | 77.2 | 39.6 | 10.6 | -8.5 | 3.9 | -51.4 | 64.4 | 15.6 | 3.4 | 14.1 | |
| Closing Cash Balance | 132.3 | 112.1 | 173.1 | 95.8 | 56.2 | 45.6 | 54.1 | 50.2 | 101.6 | 37.0 | 21.4 | 18.0 |
| Cash position | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | 20.7 | -2.6 | -11.1 | -68.0 | 47.1 | -94.8 | 88.5 | 36.4 | -24.3 | 99.2 | |
| Closing Cash Balance | 112.1 | 91.4 | 94.0 | 105.1 | 173.1 | 126.0 | 220.8 | 132.3 | 95.8 | 120.1 |
| Free Cash Flow | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -82.5 | -162.7 | -97.1 | -76.6 | -87.8 | -85.6 | -107.1 | -71.3 | -37.9 | -9.8 | 3.5 | -7.5 | |
| Real Free Cash Flow | -92.3 | -174.7 | -110.2 | -85.9 | -98.4 | -108.8 | -135.1 | -101.3 | -68.5 | -16.1 | 1.5 | -7.9 |
| Free Cash Flow | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -38.3 | -42.4 | -40.0 | -42.1 | -13.7 | -27.8 | -23.8 | -31.7 | -13.1 | -17.4 | |
| Real Free Cash Flow | -41.5 | -45.4 | -42.7 | -45.1 | -17.0 | -31.2 | -27.4 | -34.5 | -15.7 | -19.6 |
Nacenění
Finance
Efektivita
Marže
Dividenda
Ostatní
Nacenění
| Ukazatel | Aktuální | Historické | Konkurence |
|---|---|---|---|
| P/E | -5.7 | -4.5 | -1.4 |
| P/S | 7.9 | 2890.4 | 9.4 |
| P/B | -7.5 | 2.2 | 5.2 |
| P/FCF | -5 | 19.5 | -1.5 |
| Market cap | $1.1 | $2.7 |
P/E (Price to Earnings Ratio) – Poměr ceny akcie k zisku za posledních 12 měsíců. Říká, kolik korun investor zaplatí za 1 korunu zisku. Např.: P/E = 15 znamená, že pokud akcie stojí 15 Kč, firma vydělala 1 Kč za poslední rok.
Finance
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Debt to Assets | 70.2 % | 22.8 % | 0 % |
| Debt to Income | -84.7 % | -34 % | 0 % |
| Debt to Free cash flow | -74.4 % | -2780.6 % | 0 % |
| Interest expense percentage | -27.1 % | -5.7 % | 44.7 % |
| Current ratio | 4 | 8.3 | 0 |
Efektivita
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| ROE | 133 % | -27.9 % | 0 % |
| ROA | -82.9 % | -55.5 % | 0 % |
| CapEx to Revenue | 0.5 % | 144.6 % | 0 % |
| RaD to Revenue | 0 % | 23130.6 % | 0 % |
| ROEM | 467,183.0 | 155325.8 |
Marže
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Gross margin | 88.8 % | -17702.5 % | 68.7 % |
| Operating margin | -127.2 % | -52047.9 % | 35.5 % |
| Net margin | -158.6 % | -50165.9 % | 9.5 % |
Dividenda
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Dividend yield | 0 % | 0 % | 0 % |
| Dividend payout percentage | 0 % | 0 % | 0 % |
Dividend yield (Dividendový výnos) ukazuje aktuální procentuální výnos z dividend vůči ceně akcie.
Ostatní
| Ukazatel | Aktuální | Historické |
|---|---|---|
| Shares outstanding | 48.1 mil | 23.4 mil |
| Employee count | 0.2 tis | 0.2 tis |
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
